Investor Ab

Institutional investor · Portfolio as of Q3 2023

Q3 2023 Summary

Opened 3 positions, exited 3, trimmed 1. Portfolio: $2.8B across 9 positions.

Top Holdings9 positions

Checking export access…
Activity:
NDAQ

Nasdaq, Inc.

58.2M$2.8B99.8%$32.48+43.69%
16 qtrssince 2019-Q4
Unchanged
0
C

Citigroup, Inc.

40,000$1.6M0.1%$37.32+26.69%
1 qtr
New
39
MU

Micron Technology, Inc.

13,250$901,3980.0%$53.04+26.82%
5 qtrssince 2022-Q3
Unchanged
0
TIGO

Millicom International Cellular S.A.

50,000$772,5000.0%$15.71-18.34%
3 qtrssince 2023-Q1
Unchanged
0
AMZN

Amazon.com, Inc.

3,750$476,7000.0%$130.36-2.49%
2 qtrssince 2023-Q2
Unchanged
0
SWK

Stanley Black & Decker, Inc.

5,700$476,4060.0%$108.58-31.76%
9 qtrssince 2021-Q3
Unchanged
0
CCL

Carnival Corporation Ltd.

16,000$219,5200.0%———
—
AMAT

Applied Materials, Inc.

800$110,7600.0%$135.040.00%
1 qtr
New
33
??
AGILYSYS INCDelisted
Put
1,754$4,2100.0%——
1 qtr
New
23
$2.8B
AUM
9
Positions
Q3 2023
Filing
HI rating · 1.0/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2022-Q2$2,960,410,000-14.484345581%
2022-Q3$3,302,342,00011.5501569039%
2022-Q4$3,570,677,3468.12560740226%
2023-Q1$3,183,535,242-10.8422595067%
2023-Q2$2,903,938,533-8.78258563974%
2023-Q3$2,831,690,773-2.4879231836%
Activity profile
$ moved · Q3'23
New71%Increased0%Decreased15%Exited14%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.6 years
<1Q22%1-4Q11%1-2Y11%2Y+56%

Investor Ab manages $2.8B across 9 positions as of Q3 2023. Top holdings: NDAQ (99.8%), C (0.1%), MU (0.0%). Fund DNA: Concentrated Value. HoldingsIntel Score: 1/5.0.

Top holdings by portfolio weight

Total AUM$3B
NDAQ99.84%
C0.06%
MU0.03%
TIGO0.03%
AMZN0.02%
SWK0.02%
CCL0.01%
AMAT0.00%
AGILYSYS INC0.00%
NEON0.00%

Portfolio allocation by GICS sector

Sectors5
Financial Services99.90%
Technology0.04%
Communication Services0.03%
Consumer Cyclical0.02%
Industrials0.02%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Financial Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L33
Conviction38
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used